HIV and COVID-19: juxtaposition of two pandemics.
作者信息
Nkengasong John
机构信息
Africa Centres for Disease Control and Prevention, Addis Ababa W21K19, Ethiopia.
出版信息
Lancet HIV. 2022 May;9(5):e300-e301. doi: 10.1016/S2352-3018(22)00095-9.
Abstract
摘要
相似文献
1
HIV and COVID-19: juxtaposition of two pandemics.艾滋病病毒与2019冠状病毒病：两种大流行病的并置
Lancet HIV. 2022 May;9(5):e300-e301. doi: 10.1016/S2352-3018(22)00095-9.
2
COVID-19 and AIDS: Outcomes from the coexistence of two global pandemics and the importance of chronic antiretroviral therapy.2019冠状病毒病与艾滋病：两种全球大流行疾病共存的后果以及长期抗逆转录病毒治疗的重要性
J Med Virol. 2021 Feb;93(2):641-643. doi: 10.1002/jmv.26416. Epub 2020 Aug 21.
3
Maintaining ART services during COVID-19 border closures: lessons learned in Namibia.在新冠疫情边境关闭期间维持抗逆转录病毒治疗服务：纳米比亚的经验教训
Lancet HIV. 2021 Jan;8(1):e7. doi: 10.1016/S2352-3018(20)30334-9.
4
Multimonth Dispensing of Antiretroviral Therapy Protects the Most Vulnerable From 2 Pandemics at Once.抗逆转录病毒疗法的多月份配给同时保护最脆弱人群免受 2 大流行病的影响。
Glob Health Sci Pract. 2020 Jun 30;8(2):176-177. doi: 10.9745/GHSP-D-20-00160.
5
Reflecting on pandemic publishing, now and then: COVID-19 and HIV.不时反思大流行期间的出版情况：新冠疫情与艾滋病病毒
Afr J AIDS Res. 2021 Oct;20(3):189-191. doi: 10.2989/16085906.2021.1984039. Epub 2021 Oct 5.
6
Incorporating HIV Screening With COVID-19 Testing in an Urban Emergency Department During the Pandemic.在大流行期间，在城市急诊部门将 HIV 筛查与 COVID-19 检测相结合。
JAMA Intern Med. 2021 Jul 1;181(7):1001-1003. doi: 10.1001/jamainternmed.2021.0839.
7
A collision of pandemics: HIV and COVID-19.大流行病的碰撞：艾滋病毒与新冠病毒。
Lancet HIV. 2022 Jul;9(7):e453-e454. doi: 10.1016/S2352-3018(22)00132-1. Epub 2022 May 10.
8
Pandemics have psychosocial and sociocultural burdens.大流行会带来心理社会和社会文化负担。
Lancet HIV. 2020 Dec;7(12):e801-e802. doi: 10.1016/S2352-3018(20)30239-3. Epub 2020 Oct 8.
9
Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics.扩大应对艾滋病毒和新冠疫情这两种相互交织大流行的努力与支持。
JAMA. 2022 Apr 5;327(13):1227-1228. doi: 10.1001/jama.2022.3517.
10
What HIV/AIDS Taught Me About Pandemics: A Clinician's Perspective.艾滋病大流行让我学到的：一位临床医生的视角。
Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):346-347. doi: 10.1016/j.ijrobp.2020.05.038.
引用本文的文献
1
Challenges Faced by Perinatally-Infected Kenyan Adolescents and Youth Living with HIV During the COVID-19 Pandemic.新冠疫情期间肯尼亚围产期感染艾滋病毒的青少年和青年所面临的挑战
AIDS Behav. 2025 Mar 20. doi: 10.1007/s10461-025-04689-9.
2
When Pandemics Collide: Actionable Lessons in HIV Prevention, Treatment and Care During the Era of COVID-19.当大流行病相遇：在 COVID-19 时代，有关艾滋病毒预防、治疗和护理的可操作经验教训。
AIDS Behav. 2024 Oct;28(Suppl 1):1-4. doi: 10.1007/s10461-024-04482-0. Epub 2024 Sep 23.
3
Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status.喀麦隆 COVID-19 大流行前针对 SARS-CoV-2 的预先存在免疫：根据 HIV 状况的比较分析。
Front Immunol. 2023 Mar 8;14:1155855. doi: 10.3389/fimmu.2023.1155855. eCollection 2023.
4
A rare case of AIDS co-infected with COVID-19 presenting with disseminated Herpes zoster complicated with CMV and Varicella zoster virus meningoencephalitis.一例罕见的 AIDS 合并 COVID-19 感染病例，表现为播散性带状疱疹，并发 CMV 和水痘带状疱疹病毒脑膜脑炎。
Acta Biomed. 2022 Dec 16;93(6):e2022326. doi: 10.23750/abm.v93i6.13464.
本文引用的文献
1
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.在 HIV-1 感染者和非感染者中，SARS-CoV-2 重组刺突蛋白纳米颗粒疫苗的免疫原性和安全性：一项随机、对照、2A/2B 期试验。
Lancet HIV. 2022 May;9(5):e309-e322. doi: 10.1016/S2352-3018(22)00041-8.
2
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.科兴新冠疫苗在 HIV 感染者中的安全性和免疫原性：一项前瞻性队列研究。
Lancet HIV. 2022 May;9(5):e323-e331. doi: 10.1016/S2352-3018(22)00033-9. Epub 2022 Mar 23.
3
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape.在晚期 HIV 疾病中，SARS-CoV-2 持续感染会导致广泛的免疫逃逸。
Cell Host Microbe. 2022 Feb 9;30(2):154-162.e5. doi: 10.1016/j.chom.2022.01.005. Epub 2022 Jan 14.
4
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial.在南非，针对有和没有 HIV 的人群的 ChAdOx1 nCoV-19（AZD1222）疫苗对 SARS-CoV-2 的安全性和免疫原性：一项随机、双盲、安慰剂对照、1B/2A 期临床试验的中期分析。
Lancet HIV. 2021 Sep;8(9):e568-e580. doi: 10.1016/S2352-3018(21)00157-0. Epub 2021 Aug 17.
5
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis.COVID-19 封锁对 65 家南非初级保健诊所中 HIV 护理的影响：一项中断时间序列分析。
Lancet HIV. 2021 Mar;8(3):e158-e165. doi: 10.1016/S2352-3018(20)30359-3. Epub 2021 Feb 4.
Zotero 插件